Market Overview:
The global in-vitro diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing incidence of chronic diseases, rising demand for personalized medicine, and technological advancements in the field of diagnostics. The global in-vitro diagnostic market is segmented on the basis of type, application, and region. On the basis of type, this market is segmented into test equipment and test reagents. Test equipment held a larger share than test reagents in 2017 owing to its growing demand for point-of-care testing (POCT). On the basis of application, this market is divided into hospitals and clinics and diagnostic centers. Hospitals and clinics held a larger share than diagnostic centers in 2017 due to their higher utilization rates for diagnosis purposes. Geographically, this market is segmented into North America, Latin America, Europe Asia Pacific (APAC),and Middle East & Africa (MEA). In 2017 North America accounted for the largest share followed by Europe owing to factors such as early adoption rateof new technologiesand presenceof major playersin these regions .
Product Definition:
In-Vitro Diagnostic is a medical test performed on tissue or fluid samples that are removed from the body, in a laboratory setting. The purpose of these tests is to detect and diagnose diseases or health conditions. In-Vitro Diagnostics are important because they can help physicians to diagnose diseases early, when treatment is more likely to be successful.
Test Equipment:
Test equipment is used for testing the efficiency, accuracy, and reliability of diagnostic tests. It also helps to minimize the variation in results between different laboratories. The growth factor in In-Vitro Diagnostic market includes advancements such as automation of test systems and high throughput technology along with cost effective & accurate diagnosis which leads to early treatment options for patients.
Test Reagents:
Test reagents are chemicals that are added to biological samples in order to perform specific tests. The most commonly used test reagents include antibodies, enzymes, substrates and co-factors, substrate inhibitors and colorimetric agents. These products have a wide range of applications in the diagnostic industry including molecular diagnostics (PCR), immunoassays (antibody detection), clinical chemistry analyzers/instruments as well as mass spectrometers.
Application Insights:
Based on application, the global in-vitro diagnostic market is segmented into hospitals and clinics, diagnostic centers and other laboratories. Hospitals and clinics held the largest share of over 70.0% in 2017 owing to an increase in demand for point-of-care diagnostics that are used by clinicians during clinical visits or hospital admissions. The need for rapid diagnosis of infectious diseases has led to an increased focus on using automated systems at hospitals that can provide faster results than manual methods.
The introduction of advanced technologies such as handheld devices with integrated cameras has enabled healthcare professionals to take better medical images thereby aiding them with a higher level of confidence when making a diagnosis. This factor is anticipated to drive the demand for IIVD over the forecast period along with technological advancements such as AI integration into test systems which will further enhance its usage rate across various applications within hospitals & clinics settings globally.
Regional Analysis:
North America dominated the global in-vitro diagnostic market with a revenue share of over 35% in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for rapid diagnosis. Moreover, rising prevalence of chronic diseases such as cancer and diabetes has led to an increase in demand for testing services; this is expected to drive regional growth during the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare facilities & infrastructure along with growing target patient population base that requires increased health care expenditure. Furthermore, government initiatives aimed at reducing maternal mortality rates are expected boost regional market development during the estimated time frame.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. In-vitro diagnostics helps in early diagnosis and treatment of these diseases, which in turn helps to reduce their impact on the patients’ lives.
- Technological advancements: In-vitro diagnostics is constantly evolving with new technologies being developed to make the process faster, easier, and more accurate. This has led to an increase in demand for IVD products and services, as well as greater competition among manufacturers.
- Growing demand for personalized medicine: There is a growing trend towards personalized or precision medicine, where treatments are tailored specifically for individual patients based on their genetic makeup or other biomarkers. In-vitro diagnostics plays a key role in this by providing information about a patient’s health status that can be used to develop targeted therapies.
Scope Of The Report
Report Attributes
Report Details
Report Title
In-Vitro Diagnostic Market Research Report
By Type
Test Equipment, Test Reagents
By Application
Hospitals and Clinics, Diagnostic Center
By Companies
Abbott, Johnson and Johnson, BD, Danaher, Thermo Fisher Scientific, Bio-Rad, Hologic, KEM-EN-TEC Diagnostics, Medtronic, Omega Diagnostics, Ortho Clinical Diagnostics, Roche, Siemens Healthineers, Sysmex, Atlas Genetics, ELITechGroup, Biomerieux, Werfen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global In-Vitro Diagnostic Market Report Segments:
The global In-Vitro Diagnostic market is segmented on the basis of:
Types
Test Equipment, Test Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Johnson and Johnson
- BD
- Danaher
- Thermo Fisher Scientific
- Bio-Rad
- Hologic
- KEM-EN-TEC Diagnostics
- Medtronic
- Omega Diagnostics
- Ortho Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Atlas Genetics
- ELITechGroup
- Biomerieux
- Werfen
Highlights of The In-Vitro Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Test Equipment
- Test Reagents
- By Application:
- Hospitals and Clinics
- Diagnostic Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In-Vitro Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In-vitro diagnostic is a process of diagnosing diseases or conditions in vitro, which means outside the body. This includes using cells, tissues, organs or other biological samples to detect and diagnose diseases.
Some of the key players operating in the in-vitro diagnostic market are Abbott, Johnson and Johnson, BD, Danaher, Thermo Fisher Scientific, Bio-Rad, Hologic, KEM-EN-TEC Diagnostics, Medtronic, Omega Diagnostics, Ortho Clinical Diagnostics, Roche, Siemens Healthineers, Sysmex, Atlas Genetics, ELITechGroup, Biomerieux, Werfen.
The in-vitro diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In-Vitro Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In-Vitro Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In-Vitro Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In-Vitro Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In-Vitro Diagnostic Market Size & Forecast, 2020-2028
4.5.1 In-Vitro Diagnostic Market Size and Y-o-Y Growth
4.5.2 In-Vitro Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Test Equipment
5.2.2 Test Reagents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Diagnostic Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In-Vitro Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In-Vitro Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Test Equipment
9.6.2 Test Reagents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Diagnostic Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Test Equipment
10.6.2 Test Reagents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Diagnostic Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Test Equipment
11.6.2 Test Reagents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Diagnostic Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Test Equipment
12.6.2 Test Reagents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Diagnostic Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Test Equipment
13.6.2 Test Reagents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Diagnostic Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In-Vitro Diagnostic Market: Competitive Dashboard
14.2 Global In-Vitro Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Johnson and Johnson
14.3.3 BD
14.3.4 Danaher
14.3.5 Thermo Fisher Scientific
14.3.6 Bio-Rad
14.3.7 Hologic
14.3.8 KEM-EN-TEC Diagnostics
14.3.9 Medtronic
14.3.10 Omega Diagnostics
14.3.11 Ortho Clinical Diagnostics
14.3.12 Roche
14.3.13 Siemens Healthineers
14.3.14 Sysmex
14.3.15 Atlas Genetics
14.3.16 ELITechGroup
14.3.17 Biomerieux
14.3.18 Werfen
